Real-time enrollment status for this lymphatic malformations clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 3:21 AM UTC
| NCT Number | NCT05948943 |
| Recruiting Status | Recruiting |
| Condition | Lymphatic Malformations |
| Phase | PHASE2 |
| Target Enrollment | 232 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | August 18, 2026 (2 weeks ago) |
As of September 1, 2026: Clinical trial NCT05948943 is currently recruiting participants. This phase2 study for lymphatic malformations is actively seeking new participants at 18 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05948943 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05948943 was last updated 2 weeks ago (August 18, 2026). HelloStudys verifies this status automatically.